Courses
Courses for Kids
Free study material
Offline Centres
More
Store Icon
Store

Glycolate metabolism occurs in
(a) Lysosome
(b) Ribosomes
(c) Glyoxysomes
(d) Peroxisome

seo-qna
SearchIcon
Answer
VerifiedVerified
452.4k+ views
Hint: This is a small organelle present in the cytoplasm of most of the eukaryotic cells. These contain the reducing enzymes that oxidize certain molecules normally found in the cell.
Phosphoglycolate is transformed into glycolate which is transferred to peroxisomes. In the chloroplasts, glycolate biosynthesis occurs where glycolate is oxidized to glyoxylate with oxygen uptake by glycolate oxidase. With the help of glutamate i.e. glyoxylate aminotransferase, the glyoxylate is converted to glycine. All this happens within peroxisomes. Further metabolism of glycine does not occur here. The excess glyoxylate left in the peroxisomes can return to the chloroplasts so that it can be reduced to glycolate. It is or also oxidized to account for part of the carbon dioxide loss during photorespiration.
seo images

Peroxisomes oxidize certain molecules found in cells, especially the fatty acids and amino acids. The name for this comes from the basis of their reaction to produce hydrogen peroxide. But this hydrogen peroxide is toxic to the eukaryotic cells, so peroxisomes contain even catalase which gives water and oxygen from hydrogen peroxide. Thus providing a safe place for the oxidation metabolism of molecules. They also help in the biosynthesis of membrane lipids known as plasmalogens. In the cells of plants peroxisomes carry out additional functions and special types of peroxisomes have been identified in them.
So, the correct answer is 'Peroxisome'.

Note: In humans, plasmalogens are the primary ether lipids that have one or more ether linkages distinguishing them from other lipids present. The peroxisomes catalyze the synthesis of an ether precursor that undergoes further synthesis and results in a plasmalogen. Plasmalogen is associated with severe developmental conditions like rhizomelic chondrodysplasia punctata, Zellweger syndrome, and reduced levels of plasmalogens that have been observed in patients with Alzheimer's disease in the brain.